TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE
6.1. Overview
6.2. Consumables
6.3. Assays
6.3.1. Bacterial Toxicity Assays
6.3.2. Enzyme Toxicity Assays
6.3.3. Cell-Based Elisa and Western Blots
6.3.4. Receptor-Binding Assays
6.3.5. Tissue Culture Assays
6.3.6. Other Assays
6.4. Services
6.5. Equipment
6.6. Software
7. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST
7.1. Overview
7.2. ADME
7.3. Genotoxicity
7.4. Skin Irritation, Corrosion & Sensitization
7.5. Cytotoxicity
7.6. Ocular Toxicity
7.7. Organ Toxicity
7.8. Dermal Toxicity
7.9. Phototoxicity
7.10. Other End Point & Tests
8. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
8.1. Overview
8.2. Pharmaceutical & Biopharmaceutical
8.3. Consumer Care
8.4. Food
8.5. Others
9. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1. Overview
9.2. Cell Culture
9.3. High-throughput
9.4. Toxicogenomic
10. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
10.1. Overview
10.2. Cellular Assays
10.3. Biochemical Assays
10.4. Molecular Toxicology Assays
10.5. Ex-vivo Models
10.6. In Silico Models
11. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global In Vitro Toxicology Testing Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Global In Vitro Toxicology Testing Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2023
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Charles River Laboratories
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Covance
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Thermo Fisher Scientific
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Eurofins Scientific
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. SGS SA
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Merck KGaA
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Cyprotex
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. PROMEGA CORPORATION
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Gentronix Limited
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. BIORELIANCE CORPORATION
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 13 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 14 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 15 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 16 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 17 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 18 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 19 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 20 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 21 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 22 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 23 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 24 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 25 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 26 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 27 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 28 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 29 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 30 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 31 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 32 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 33 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 34 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 35 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 36 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 37 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 38 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 39 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 40 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 41 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 42 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 43 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 44 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 45 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 46 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 47 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 48 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 49 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 50 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 51 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 52 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 53 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 54 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 58 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 63 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 64 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 65 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 66 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 67 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 68 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 69 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 70 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 71 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 72 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 73 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 74 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 75 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 76 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 77 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 78 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 79 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 80 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 81 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 82 AUSTRALIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 83 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 84 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 85 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 86 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 87 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 88 REST OF ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 89 REST OF ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 93 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 94 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 95 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 96 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 97 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 98 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 99 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 100 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 101 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 102 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 103 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 104 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 105 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 106 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 107 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2032 (USD BILLION)
TABLE 109 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2032 (USD BILLION)
TABLE 110 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2032 (USD BILLION)
TABLE 111 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 112 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 4 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY PRODUCT & SERVICE, 2023
FIGURE 5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY TOXICITY ENDPOINT & TEST, 2023
FIGURE 6 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY INDUSTRY, 2023
FIGURE 7 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 8 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY METHOD, 2023
FIGURE 9 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 ASIA-PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 REST OF THE WORLD: IN VITRO TOXICOLOGY TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 14 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 15 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
FIGURE 17 COVANCE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 COVANCE: SWOT ANALYSIS
FIGURE 19 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 21 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 23 SGS SA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 SGS SA.: SWOT ANALYSIS
FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 MERCK KGAA: SWOT ANALYSIS
FIGURE 27 CYPROTEX: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 CYPROTEX: SWOT ANALYSIS
FIGURE 29 PROMEGA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 PROMEGA CORPORATION: SWOT ANALYSIS
FIGURE 31 GENTRONIX LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GENTRONIX LIMITED: SWOT ANALYSIS
FIGURE 33 BIORELIANCE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 BIORELIANCE CORPORATION: SWOT ANALYSIS
